AV Reentrant Tachycardia: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by drspine

AV Reentrant Tachycardia Introduction (What it is)

AV Reentrant Tachycardia is a fast heart rhythm caused by an electrical “loop” that repeatedly activates the heart.
It usually involves the normal AV node pathway plus an extra pathway (an accessory pathway) between the atria and ventricles.
It often starts and stops suddenly and can cause palpitations, chest discomfort, or lightheadedness.
Clinicians commonly discuss it in emergency care, outpatient cardiology, and electrophysiology (heart rhythm) clinics.

Why AV Reentrant Tachycardia used (Purpose / benefits)

AV Reentrant Tachycardia is not something clinicians “use” like a device or medication; it is a diagnosis and a rhythm mechanism. The purpose of identifying AV Reentrant Tachycardia is to accurately explain why a patient is having episodes of rapid heartbeat and to guide safe evaluation and management.

Recognizing AV Reentrant Tachycardia can help clinicians:

Clarify the cause of symptoms such as sudden palpitations, shortness of breath, chest pressure, fatigue, or near-fainting.
Differentiate among supraventricular tachycardias (SVTs)—a group of rapid rhythms that start above the ventricles—because the safest tests and treatments can vary by rhythm mechanism.
Assess whether an accessory pathway is present, which matters because some accessory pathways can conduct impulses quickly under certain conditions.
Support risk-aware decision-making about monitoring, activity considerations, medication choices, and when referral to an electrophysiologist is appropriate.
Identify candidates for rhythm-targeted therapy, including catheter ablation in selected cases, when symptoms are frequent or burdensome. The decision depends on clinician judgment and individual factors.

Overall, the “benefit” is precision: naming AV Reentrant Tachycardia correctly helps match the clinical approach to the underlying electrical circuit rather than treating all fast rhythms as the same problem.

Clinical context (When cardiologists or cardiovascular clinicians use it)

AV Reentrant Tachycardia is typically considered in scenarios like:

Sudden-onset, sudden-offset episodes of a rapid, regular heartbeat (paroxysmal palpitations)
Emergency department visits for a rapid regular rhythm that responds to AV-node–focused interventions (as determined by clinicians)
A young or middle-aged person with recurrent SVT symptoms and a normal resting heart structure on initial testing
An ECG pattern suggesting pre-excitation (often discussed in relation to Wolff-Parkinson-White pattern), prompting evaluation for an accessory pathway
Episodes of rapid rhythm documented on ambulatory monitoring (Holter, patch monitor, event recorder)
Planning for or interpreting an electrophysiology (EP) study, where the circuit can be mapped and sometimes treated
Distinguishing AV Reentrant Tachycardia from other causes of narrow- or wide-complex tachycardia (for example, atrial flutter, atrial tachycardia, AV nodal reentrant tachycardia, or ventricular tachycardia)

Contraindications / when it’s NOT ideal

Because AV Reentrant Tachycardia is a diagnosis, “contraindications” apply more to specific management strategies and to situations where another diagnosis is more likely. Clinicians may consider other approaches when:

The rhythm is irregular or the ECG suggests a different mechanism (for example, atrial fibrillation rather than a reentrant SVT).
There is evidence of hemodynamic instability (such as very low blood pressure, severe chest pain, or fainting) where urgent stabilization takes priority and the exact mechanism may be clarified afterward.
The episode is a wide-complex tachycardia and ventricular tachycardia is a concern; clinicians typically prioritize safety and assume ventricular tachycardia until proven otherwise.
There is suspected pre-excited atrial fibrillation (atrial fibrillation with conduction over an accessory pathway). In that setting, some AV-node–slowing medications are generally avoided because they may worsen conduction over the accessory pathway; the best choice varies by clinician and case.
Symptoms are better explained by non-arrhythmic causes (for example, panic symptoms, anemia, hyperthyroidism), requiring broader evaluation.
An invasive strategy (such as EP study or catheter ablation) is being considered but is not suitable right now due to factors like active infection, inability to lie flat, or clinical issues that increase procedural risk. Suitability varies by clinician and case.

How it works (Mechanism / physiology)

Core mechanism: reentry.
AV Reentrant Tachycardia occurs when an electrical impulse repeatedly travels in a circular path (a reentrant circuit). This loop causes the heart to activate rapidly and regularly.

Key anatomy and pathways involved:

Atria: the upper chambers where electrical activation normally begins.
AV node: the “gatekeeper” between atria and ventricles that normally slows conduction and helps coordinate timing.
His–Purkinje system: the specialized conduction network that rapidly distributes impulses through the ventricles.
Accessory pathway: an extra connection (outside the AV node) that can allow impulses to travel between atria and ventricles. Accessory pathways can conduct from atrium to ventricle, ventricle to atrium, or both, depending on pathway properties.

Two main circuit directions (high-level):

Orthodromic AV Reentrant Tachycardia: the impulse typically goes down to the ventricles through the AV node/His–Purkinje system and returns back to the atria through the accessory pathway. This often produces a narrow QRS tachycardia because ventricular activation uses the normal conduction system.
Antidromic AV Reentrant Tachycardia: the impulse goes down through the accessory pathway and returns back through the AV node. This can produce a wide QRS tachycardia because the ventricles are activated outside the usual His–Purkinje pattern.

Time course and clinical pattern:

AV Reentrant Tachycardia is usually paroxysmal (episodic), with abrupt start and stop.
Episodes may be brief or prolonged, and frequency varies widely.
Between episodes, many people have a normal rhythm; some may show pre-excitation on a resting ECG if the accessory pathway conducts from atrium to ventricle at rest.

Reversibility and interpretation:

An episode can often be interrupted by interventions that change conduction through the AV node or alter the reentrant circuit. The specific intervention and appropriateness depend on the clinical setting and clinician judgment.
Definitive interpretation often relies on an ECG captured during symptoms and, in some cases, EP testing to confirm the circuit.

AV Reentrant Tachycardia Procedure overview (How it’s applied)

AV Reentrant Tachycardia is not itself a procedure. In practice, clinicians “apply” the concept by diagnosing the rhythm mechanism and selecting an evaluation and management plan. A typical high-level workflow looks like this:

Evaluation / exam – Symptom history (onset/offset, triggers, duration, associated dizziness, chest pressure, shortness of breath) – Review of medications, stimulants, and relevant medical history – Physical exam and vital signs – Baseline 12-lead ECG (even if the person is not currently in tachycardia)
Preparation (when further testing is needed) – Choosing a monitoring method to capture an episode (short-term Holter vs longer event or patch monitoring) – Basic labs or additional cardiac testing when indicated to rule out contributing conditions (varies by clinician and case)
Intervention / testing – Capturing the rhythm on ECG during symptoms (in clinic, emergency care, or via monitoring) – Using ECG features to distinguish AV Reentrant Tachycardia from other SVTs (for example, QRS width, relationship of atrial and ventricular signals) – Referral to an electrophysiologist when episodes are recurrent, unclear, or when ablation is being considered – EP study (in selected cases): catheters are used to record intracardiac signals, induce the tachycardia, and identify the accessory pathway’s location and properties – Catheter ablation (in selected cases): energy is delivered to interrupt the accessory pathway and prevent the circuit from recurring
Immediate checks – Post-episode or post-procedure rhythm assessment (ECG monitoring) – Reviewing for recurrence symptoms and any complications (if an invasive procedure occurred)
Follow-up – Symptom review and monitoring plan – Discussion of long-term rhythm strategy (observation, medications, or post-ablation follow-up), tailored to the person’s clinical context

Types / variations

Clinicians describe AV Reentrant Tachycardia using several practical categories:

Orthodromic AV Reentrant Tachycardia
Often narrow-complex SVT
May show retrograde atrial activation (atria activated after ventricles) depending on pathway properties
Antidromic AV Reentrant Tachycardia
Typically wide-complex tachycardia
Can resemble ventricular tachycardia on ECG, which is why careful evaluation is important
Manifest vs concealed accessory pathways
Manifest: the accessory pathway conducts from atrium to ventricle during normal rhythm, producing ECG evidence of pre-excitation.
Concealed: the accessory pathway does not show pre-excitation on resting ECG (often conducts only from ventricle to atrium), yet can still support AV Reentrant Tachycardia.
Accessory pathway location (examples)
Left free wall, right free wall, or septal regions (near the heart’s central dividing structures)
Location influences ECG patterns and mapping strategy during EP study
Incessant or atypical variants (less common)
Some reentrant rhythms using an accessory pathway can be more sustained or repetitive and may affect heart function over time if frequent. The clinical impact varies by clinician and case.

Pros and cons

Pros:

Helps explain sudden, episodic palpitations with a clear physiologic mechanism (reentry)
Often diagnosable with ECG evidence, especially when captured during symptoms
Typically has well-established evaluation pathways (monitoring, ECG interpretation, EP consultation)
In selected patients, catheter ablation can be curative by interrupting the accessory pathway
Supports safer decision-making by distinguishing AV Reentrant Tachycardia from other SVTs and from ventricular tachycardia
Can be managed with individualized strategies (observation, medications, ablation) depending on symptom burden and risk context

Cons:

Episodes can be frightening and disruptive, even when not immediately dangerous
If the rhythm is not captured on ECG, diagnosis can be delayed and require prolonged monitoring
Some presentations overlap with other tachycardias, making misclassification possible without careful evaluation
Wide-complex forms and pre-excitation scenarios can create higher-stakes diagnostic decisions
Medications may help some people but can be limited by side effects or incomplete control; response varies
Invasive testing/ablation, when pursued, carries procedural risks and may not be appropriate for everyone (varies by clinician and case)

Aftercare & longevity

Aftercare depends on whether AV Reentrant Tachycardia is managed with observation, medications, or an invasive strategy such as catheter ablation. In general, outcomes and “longevity” of control are influenced by:

Accurate rhythm documentation: Capturing the rhythm on ECG helps ensure the plan matches the mechanism.
Accessory pathway properties and location: These influence how the tachycardia behaves and, if ablation is performed, how complex mapping may be.
Symptom burden and episode frequency: People with rare brief episodes may have a different follow-up approach than those with frequent recurrences.
Coexisting heart conditions: Structural heart disease, cardiomyopathy, valve disease, or coronary disease can affect tolerance of tachycardia and overall care planning.
Triggers and contributing factors: Sleep deprivation, alcohol, stimulants, acute illness, and thyroid abnormalities can influence arrhythmia frequency in some individuals.
Follow-up adherence: Keeping cardiology follow-up and completing recommended monitoring can clarify recurrence vs non-arrhythmic symptoms.
Post-ablation course (if performed): Clinicians often reassess symptoms and ECG findings over time; recurrence risk and follow-up intervals vary by clinician and case.

“Recovery” after an episode is usually immediate once normal rhythm returns, but fatigue or heightened symptom awareness may last longer for some people. If a procedure was performed, recovery depends on access site healing and the individual’s overall health.

Alternatives / comparisons

AV Reentrant Tachycardia is one specific SVT mechanism. Alternatives and comparisons usually involve either different diagnoses or different management strategies.

AV Reentrant Tachycardia vs AV nodal reentrant tachycardia (AVNRT)
Both can cause sudden regular palpitations and narrow-complex SVT.
AVNRT uses reentry within or near the AV node; AV Reentrant Tachycardia uses an accessory pathway as part of the circuit.
Distinguishing them may require ECG detail or EP study, especially when episodes are not captured clearly.
AV Reentrant Tachycardia vs atrial tachycardia / atrial flutter
Atrial tachycardia and flutter originate from atrial tissue circuits or focal triggers, not necessarily requiring an accessory pathway.
They may have different ECG patterns and treatment strategies.
AV Reentrant Tachycardia vs ventricular tachycardia (VT)
Wide-complex AV Reentrant Tachycardia can look like VT on ECG.
Clinicians often treat wide-complex tachycardia cautiously because VT can be more immediately dangerous, particularly in structural heart disease.
Observation/monitoring vs medication vs catheter ablation
Observation/monitoring: often considered when episodes are rare, brief, or minimally symptomatic, and when risk features are not present (as assessed by clinicians).
Medication: may reduce episode frequency or slow conduction in parts of the circuit; choice depends on the mechanism, comorbidities, and clinician preference.
Catheter ablation: aims to eliminate the accessory pathway and prevent recurrence; it is an invasive strategy and suitability varies by clinician and case.
Noninvasive testing vs EP study
Noninvasive: ECG, ambulatory monitoring, exercise testing (in selected cases) can provide key clues.
EP study: provides the most direct mechanism confirmation and can enable ablation during the same procedure in appropriate patients.

AV Reentrant Tachycardia Common questions (FAQ)

Q: What does AV Reentrant Tachycardia feel like?
Many people describe sudden, fast, regular pounding in the chest (palpitations). Some also notice shortness of breath, chest pressure, anxiety, lightheadedness, or fatigue. Symptoms vary based on heart rate, episode duration, and underlying health.

Q: Is AV Reentrant Tachycardia dangerous?
Often it is tolerated, especially in otherwise healthy hearts, but it can still cause significant symptoms and lead to urgent evaluations. Risk depends on the rhythm type, the accessory pathway’s properties, and the person’s overall cardiac condition. Clinicians assess risk on a case-by-case basis.

Q: How is AV Reentrant Tachycardia diagnosed?
Diagnosis typically relies on an ECG captured during an episode or on ambulatory monitoring that records the rhythm during symptoms. A resting ECG may show signs of an accessory pathway in some people, but not all. An EP study can confirm the mechanism when needed.

Q: Does AV Reentrant Tachycardia require hospitalization?
Some episodes are evaluated and treated in emergency care, while others are handled entirely outpatient. Hospitalization depends on symptom severity, blood pressure stability, other medical conditions, and how easily normal rhythm is restored. The approach varies by clinician and case.

Q: What are common treatments for AV Reentrant Tachycardia?
Treatments may include observation, medications to reduce episodes, and catheter ablation to interrupt the accessory pathway. Acute episode management and long-term prevention are handled differently, and the plan depends on the documented rhythm and clinical context. Decisions vary by clinician and case.

Q: Is catheter ablation painful, and what is recovery like?
Ablation is typically performed with sedation or anesthesia, so discomfort during the procedure is often limited. Afterward, people may have temporary soreness or bruising where catheters were inserted, and clinicians may recommend short-term activity modifications. Recovery experience varies by individual and procedural details.

Q: How long do results last after treatment?
With medications, benefit lasts only while the medication is taken and tolerated, and control may be incomplete in some cases. With catheter ablation, many patients have long-term elimination of the circuit, but recurrence can occur. Long-term durability varies by clinician and case.

Q: Are there activity restrictions with AV Reentrant Tachycardia?
Some people continue usual activities between episodes, while others limit activity due to symptoms or fear of recurrence. Clinicians individualize guidance based on episode pattern, associated symptoms (like fainting), and whether an accessory pathway with higher-risk features is suspected. Recommendations vary by clinician and case.

Q: How much does evaluation or treatment cost?
Costs vary widely depending on location, insurance coverage, testing (monitoring vs EP study), emergency care use, and whether a procedure is performed. Facility fees, professional fees, and anesthesia or imaging needs can also affect total cost. For a meaningful estimate, billing departments typically need the planned testing and setting.